GNE-375

CAS No. 1926989-06-1

GNE-375( GNE375 )

Catalog No. M13018 CAS No. 1926989-06-1

GNE-375 is a potent, selective BRD9 inhibitor with IC50 of 5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 315 In Stock
5MG 278 In Stock
10MG 432 In Stock
25MG 708 In Stock
50MG 995 In Stock
100MG 1460 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GNE-375
  • Note
    Research use only, not for human use.
  • Brief Description
    GNE-375 is a potent, selective BRD9 inhibitor with IC50 of 5 nM.
  • Description
    GNE-375 is a potent, selective BRD9 inhibitor with IC50 of 5 nM, displays >480-fold selectivity over BRD4, CECR2, and TAF1; decreases BRD9 binding to chromatin, and decreases expression of ALDH1A1, a gene previously shown to be important in drug tolerance; shows remarkable potency in preventing the emergence of a drug tolerant population in EGFR mutant PC9 cells treated with EGFR inhibitors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GNE375
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1926989-06-1
  • Formula Weight
    451.523
  • Molecular Formula
    C25H29N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (110.74 mM)
  • SMILES
    O=C1C(NC=C2)=C2C(C3=CC(OC)=C(C(N4CCOCC4)=O)C=C3OC)=CN1C/C=C/C
  • Chemical Name
    (E)-6-(but-2-en-1-yl)-4-(2,5-dimethoxy-4-(morpholine-4-carbonyl)phenyl)-2-methyl-1,6-dihydro-7H-pyrrolo[2,3-c]pyridin-7-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Crawford TD, et al. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3534-3541.
molnova catalog
related products
  • LP99

    LP99 is the first potent and selective BRD7/9 bromodomain inhibitor with Kd of 99 nM for BRD9; inhibits IL‐6 secretion from THP‐1 cells in a dose‐dependent manner.

  • biBET

    biBET is a potent, selective, bivalent inhibitor of BET bromodomains.

  • BET inhibitor CF53

    BET inhibitor CF53 is a highly potent, orally active inhibitor of bromodomain and extra-terminal (BET) with Ki of <1 nM (BRD4 BD1).